TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 2 | -1 | -6 | -11 | -3 | -41 | -10 |
| P | %wins | 100 | 0 | 0 | 0 | 0 | 0 | 17 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/12/21 16:06 | 8/12/21 | ENVX | Enovix Corp | Electr | ElcEq | Miscellaneous Electrical Mach | Pietzke Steffen | CA | O | CFO | P | 295 | 14.75 | 0 | 20 | 999% | 22 | D | |||||||||||||||
7/21/20 19:59 | 7/21/20 | ALXO | Alx Oncology Holdings Inc | DE | Health | Drug | Pharmaceutical Preparations | Pietzke Steffen | CA | O | VP Fin,C | P | 57 | 19.00 | 0 | 3 | New | 3 | D | ||||||||||||||
7/2/18 20:58 | 7/2/18 | TCDA | Tricida, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pietzke Steffen | CA | O | VP Fin,C | P | 200 | 19.00 | 0 | 11 | New | 11 | D | ||||||||||||||
12/7/15 18:48 | 12/7/15 | PDLI | Pdl Biopharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Pietzke Steffen | NV | O | Controll | P | 75 | 3.64 | 10 | 21 | New | 21 | I | -48 | -48 | -38 | -27 | -19 | -2 | -4 | 0 | 2 | -1 | -6 | -11 | -3 | -41 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |